Forensic biomarkers of lethal traumatic brain injury

Standard

Forensic biomarkers of lethal traumatic brain injury. / Zwirner, Johann; Kulakofsky, Rachel; Fitzek, Antonia; Schröder, Ann Sophie; Bohnert, Simone; Franke, Heike; Renné, Thomas; Tse, Rexson; Ondruschka, Benjamin.

In: INT J LEGAL MED, Vol. 136, No. 3, 05.2022, p. 871-886.

Research output: SCORING: Contribution to journalSCORING: Review articleResearch

Harvard

APA

Vancouver

Bibtex

@article{a8e02eb59a924ec5b4ae2ae797b063f8,
title = "Forensic biomarkers of lethal traumatic brain injury",
abstract = "Traumatic brain injury (TBI) is a major cause of death and its accurate diagnosis is an important concern of daily forensic practice. However, it can be challenging to diagnose TBI in cases where macroscopic signs of the traumatic head impact are lacking and little is known about the circumstances of death. In recent years, several post-mortem studies investigated the possible use of biomarkers for providing objective evidence for TBIs as the cause of death or to estimate the survival time and time since death of the deceased. This work systematically reviewed the available scientific literature on TBI-related biomarkers to be used for forensic purposes. Post-mortem TBI-related biomarkers are an emerging and promising resource to provide objective evidence for cause of death determinations as well as survival time and potentially even time since death estimations. This literature review of forensically used TBI-biomarkers revealed that current markers have low specificity for TBIs and only provide limited information with regards to survival time estimations and time since death estimations. Overall, TBI fatality-related biomarkers are largely unexplored in compartments that are easily accessible during autopsies such as urine and vitreous humor. Future research on forensic biomarkers requires a strict distinction of TBI fatalities from control groups, sufficient sample sizes, combinations of currently established biomarkers, and novel approaches such as metabolomics and mi-RNAs.",
author = "Johann Zwirner and Rachel Kulakofsky and Antonia Fitzek and Schr{\"o}der, {Ann Sophie} and Simone Bohnert and Heike Franke and Thomas Renn{\'e} and Rexson Tse and Benjamin Ondruschka",
note = "{\textcopyright} 2022. The Author(s).",
year = "2022",
month = may,
doi = "10.1007/s00414-022-02785-2",
language = "English",
volume = "136",
pages = "871--886",
journal = "INT J LEGAL MED",
issn = "0937-9827",
publisher = "Springer",
number = "3",

}

RIS

TY - JOUR

T1 - Forensic biomarkers of lethal traumatic brain injury

AU - Zwirner, Johann

AU - Kulakofsky, Rachel

AU - Fitzek, Antonia

AU - Schröder, Ann Sophie

AU - Bohnert, Simone

AU - Franke, Heike

AU - Renné, Thomas

AU - Tse, Rexson

AU - Ondruschka, Benjamin

N1 - © 2022. The Author(s).

PY - 2022/5

Y1 - 2022/5

N2 - Traumatic brain injury (TBI) is a major cause of death and its accurate diagnosis is an important concern of daily forensic practice. However, it can be challenging to diagnose TBI in cases where macroscopic signs of the traumatic head impact are lacking and little is known about the circumstances of death. In recent years, several post-mortem studies investigated the possible use of biomarkers for providing objective evidence for TBIs as the cause of death or to estimate the survival time and time since death of the deceased. This work systematically reviewed the available scientific literature on TBI-related biomarkers to be used for forensic purposes. Post-mortem TBI-related biomarkers are an emerging and promising resource to provide objective evidence for cause of death determinations as well as survival time and potentially even time since death estimations. This literature review of forensically used TBI-biomarkers revealed that current markers have low specificity for TBIs and only provide limited information with regards to survival time estimations and time since death estimations. Overall, TBI fatality-related biomarkers are largely unexplored in compartments that are easily accessible during autopsies such as urine and vitreous humor. Future research on forensic biomarkers requires a strict distinction of TBI fatalities from control groups, sufficient sample sizes, combinations of currently established biomarkers, and novel approaches such as metabolomics and mi-RNAs.

AB - Traumatic brain injury (TBI) is a major cause of death and its accurate diagnosis is an important concern of daily forensic practice. However, it can be challenging to diagnose TBI in cases where macroscopic signs of the traumatic head impact are lacking and little is known about the circumstances of death. In recent years, several post-mortem studies investigated the possible use of biomarkers for providing objective evidence for TBIs as the cause of death or to estimate the survival time and time since death of the deceased. This work systematically reviewed the available scientific literature on TBI-related biomarkers to be used for forensic purposes. Post-mortem TBI-related biomarkers are an emerging and promising resource to provide objective evidence for cause of death determinations as well as survival time and potentially even time since death estimations. This literature review of forensically used TBI-biomarkers revealed that current markers have low specificity for TBIs and only provide limited information with regards to survival time estimations and time since death estimations. Overall, TBI fatality-related biomarkers are largely unexplored in compartments that are easily accessible during autopsies such as urine and vitreous humor. Future research on forensic biomarkers requires a strict distinction of TBI fatalities from control groups, sufficient sample sizes, combinations of currently established biomarkers, and novel approaches such as metabolomics and mi-RNAs.

U2 - 10.1007/s00414-022-02785-2

DO - 10.1007/s00414-022-02785-2

M3 - SCORING: Review article

C2 - 35226180

VL - 136

SP - 871

EP - 886

JO - INT J LEGAL MED

JF - INT J LEGAL MED

SN - 0937-9827

IS - 3

ER -